Only time will tell what is next in the landscape of tobacco and nicotine regulation from the White House and the FDA.
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
Addresses the significant threat of antimicrobial resistance.
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback